drugset
drugset / Trial / NCT00818740

Pharmacokinetic Study of ORM-12741 in Healthy Volunteers

NCT00818740 ↗

Phase 1 Completed 12 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine pharmacokinetic parameters of ORM-12741 in healthy volunteers.

Timeline

Start
2009-01
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ORM-12741 Small molecule — Intravenous

Indications

No indication recorded.